Hemorheology and hemodynamics: Dove andare?

Clinical Hemorheology and Microcirculation

Volumn 35, Issue 1-2, 2006, Pages 37-43

  Meiselman, Herbert J ^a   Baskurt, Oguz K ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Hemodynamics; Hemorheology; RBC aggregation; Therapy; Viscosity

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN;

BLOOD RHEOLOGY; BLOOD VISCOSITY; BORDERLINE HYPERTENSION; CONFERENCE PAPER; DIET THERAPY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; ERYTHROCYTE AGGREGATION; HEMODYNAMICS; HUMAN; HYPERTENSION; KINESIOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA VISCOSITY; SEPSIS; TISSUE PERFUSION;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD VISCOSITY; CALCIUM CHANNEL BLOCKERS; DIURETICS; ERYTHROCYTE AGGREGATION; HEMATOLOGIC DISEASES; HEMODYNAMIC PROCESSES; HEMORHEOLOGY; HUMANS; HYPOGLYCEMIC AGENTS; SEPSIS;

EID: 33746465360     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (61)

1. R.S. Ajmani, Hypertension and hemorheology, Clin. Hemorheol. 17 (1997), 397-420.
2. E. Alt, B.R. Amann-Vesti, C. Madl, G. Funk and R. Koppensteiner, Platelet aggregation and blood rheology in severe sepsis/septic shock, Clin. Hemorheol. Microcirc. 30 (2004), 107-115.
3. O.K. Baskurt, R.A. Farley and H.J. Meiselman, Erythrocyte aggregation tendency and cellular properties in horse, human, and rat: a comparative study, Am. J. Physiol. 273 (1997), H2604-H2612.
4. O.K. Baskurt, B.A. Meiselman, S.R. Meiselman, H.J. Meiselman and R. Elsner, Rheological behavior of bowhead whale blood, Biorheology 39 (2002), 653.
5. O.K. Baskurt and H.J. Meiselman, Blood rheology and hemodynamics, Semin. Thromb. Hemost. 29 (2003), 435-450.
6. O.K. Baskurt, O. Yalcin and H.J. Meiselman, Hemorheology and vascular control mechanisms, Clin. Hemorheol. Microcirc. 30 (2004), 169-178.
7. R.M. Bauersachs, S.J. Shaw, A. Zeidler and H.J. Meiselman, Red blood cell aggregation and blood viscoelasticity in poorly controlled type 2 diabetes mellitus, Clin. Hemorheol. 9 (1989), 935-952.
8. H. Baumler, B. Neu, E. Donath and H. Kiesewetter, Basic phenomena of red blood cell rouleaux formation, Biorheology 36 (1999), 439-442.
9. J.J. Bishop, P.R. Nance, A.S. Popel, M. Intaglietta and P.C. Johnson, Effect of erythrocyte aggregation on velocity profiles in venules, Am. J. Physiol. Heart Circ. Physiol. 280 (2001), H222-H236.
10. J.J. Bishop, P.R. Nance, A.S. Popel, M. Intaglietta and P.C. Johnson, Erythrocyte margination and sedimentation in skeletal muscle venules, Am. J. Physiol. Heart Circ. Physiol. 281 (2001), H951-H958.
11. J.J. Bishop, P.R. Nance, A.S. Popel, M. Intaglietta and P.C. Johnson, Relationship between erythrocyte aggregate size and flow rate in skeletal muscle venules, Am. J. Physiol. Heart Circ. Physiol. 286 (2004), H113-H120.
12. J.J. Bishop, A.S. Popel, M. Intaglietta and P.C. Johnson, Effects of erythrocyte aggregation and venous network geometry on red blood cell axial migration, Am. J. Physiol. Heart Circ. Physiol. 281 (2001), H939-H950.
13. J.J. Bishop, A.S. Popel, M. Intaglietta and P.C. Johnson, Rheological effects of red blood cell aggregation in the venous network: a review of recent studies, Biorheology 38 (2001), 263-274.
14. J.J. Bishop, A.S. Popel, M. Intaglietta and P.C. Johnson, Effect of aggregation and shear rate on the dispersion of red blood cells flowing in venules, Am. J. Physiol. Heart Circ. Physiol. 283 (2002), H1985-H1996.
15. L. Bogar, Hemorheology and hypertension, Clin. Hemorheol. Microcirc. 26 (2002), 81-83.
16. M. Cabel, H.J. Meiselman, A.S. Popel and P.C. Johnson, Contribution of red blood cell aggregation to venous vascular resistance in skeletal muscle, Am. J. Physiol. 272 (1997), H1020-H1032.
17. R.Y.Z. Chen, R.D. Carlin, S. Simchon, K.M. Jan and S. Chien, Effects of dextran-induced hyperviscosity on regional blood flow and hemodynamics in dogs, Am. J. Physiol. 256 (1989), H898-H905.
18. S. Chien, Biophysical behaviour of red cells in suspensions, in: The Red Blood Cell, D.M. Surgenor, ed., Academic Press, New York, 1975, pp. 1031-1133.
19. S. Chien, J. Dormandy, E. Ernst and A. Matrai, Clinical Hemorheology, Martinus Nijhoff Publ., Dordrecht/Boston/ Lancaster, 1987.
20. S. Chien and L.A. Sung, Physicochemical basis and clinical implications of red cell aggregation, Clin. Hemorheol. 7 (1987), 71-91.
21. B. Chong-Martinez, T.A. Buchanan, R. Wenby and H.J. Meiselman, Decreased red blood cell aggregation subsequent to improved glycemic control in type 2 diabetes mellitus, Diabetic Med. 20 (2003), 301-306.
22. G.R. Cokelet, H.J. Meiselman and D.E. Brooks, Erythrocyte Mechanics and Blood Flow, A.R. Liss, New York, 1980.
23. L. Dintenfass, Hyperviscosity and Hyperviscosemia, MTP Press, Lancaster, 1985.
24. E.M. Drost, G. Kassabian, H.J. Meiselman, D. Gelmont and T.C. Fisher, Increased rigidity and priming of polymorphonuclear leukocytes in sepsis, Am. J. Respir. Crit. Care Med. 159 (1999), 1696-1702.
25. A.M. Ehrly, Therapeutic Hemorheology, Springer-Verlag, Berlin, 1991.
26. F.G.R. Fowkes, G.D.O. Lowe, A. Rumley, S.E. Lennie, F.B. Smith and P.T. Donnat, The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74 years, Eur. Heart J. 14 (1993), 597-601.
27. C. Le Devehat, T. Khodabandehlou and M. Vimeux, Impaired hemorheological properties in diabetic patient with lower limb ischemia, Clin. Hemorheol. Microcirc. 25 (2001), 43-48.
28. A.J. Lee, Hemorheological, platelet and endothelial factors in essential hypertension, J. Hum. Hyperten. 16 (2002), 529-531.
29. R.L. Letcher, S. Chien, T.G. Pickering and J.H. Laragh, Elevated blood viscosity in patients with borderline essential hypertension, Hypertension 5 (1983), 757-762.
30. R.L. Letcher, S. Chien, T.G. Pickering, J.E. Sealey and J.H. Laragh, Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects, Am. J. Med. 70 (1981), 1202.
31. T. Linde, B. Sandhagen, A. Hagg, C. Morlin and B.G. Danielson, Decreased blood viscosity and serum levels of erythropoietin after anti-hypertensive treatment with amlodipine or metoprolol, J. Hum. Hyperten. 19 (1996), 199-205.
32. G.Y. Lip, A.D. Blann and D.G. Beevers, Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension, J. Hypertension 17 (1999), 1203-1207.
33. H.H. Lipowsky, S. Usami and S. Chien, In vivo measurement of apparent viscosity and microvessel hematocrit in the mesertary of the cat, Microvasc. Res. 19 (1980), 297-319.
34. M. London, The role of blood rheology in regulating blood pressure, Clin. Hemorheol. 17 (1997), 93-106.
35. G.D.O. Lowe, Clinical Blood Rheology, CRC Press, Boca Raton, FL, 1988.
36. M. Martinez, A. Vaya, F. Labios, V. Guiral and J. Aznar, The effect of long-term treatment with hypertensive drugs on blood viscosity and erythrocyte deformability, Clin. Hemorheol. Microcirc. 17 (1997), 193-198.
37. C.B. McKay and H.J. Meiselman, Osmolality-mediated Fahraeus and Fahraeus-Lindqvist effects for human RBC suspensions, Am. J. Physiol. 254 (1988), H238-H249.
38. C.B. McKay and H.J. Meiselman, Osmololity and hematocrit mediated flow behavior of RBC suspensions in 33 um ID tubes, Biorheology 26 (1989), 863-874.
39. H.J. Meiselman, Hemorheological alterations in hypertension, Clin. Hemorheol. Microcirc. 21 (2000), 195-200.
40. H.J. Meiselman, M.A. Castellini and R. Elsner, Hemorheological behavior of seal blood, Clin. Hemorheol. 12 (1992), 657-675.
41. A.V. Muravyov, H.J. Meiselman, V.V. Yakusevich and A.V. Zamishlayev, Effects of antihypertensive therapy on hemorheological profiles in female hypertensive patients with initially low or high whole blood viscosity, Clin. Hemorheol. Microcirc. 26 (2002), 135.
42. A.V. Muravyov, L.G. Zaitsev, A.A. Muravyov, V.V. Yakusevich and A.M. Sirotkina, Effects of Ramipril and Isradipin on hemorheological profiles in patients with arterial hypertension, Clin. Hemorheol. Microcirc. 18 (1998), 185-190.
43. B. Neu and H.J. Meiselman, Depletion-mediated red blood cell aggregation in polymer solutions, Biophys. J. 83 (2002), 2482-2490.
44. B. Neu, S.O. Sowemimo-Coker and H.J. Meiselman, Cell-cell affinity of senescent human erythrocytes, Biophys. J. 85 (2003), 75-84.
45. A.S. Popel, P.C. Johnson, M.V. Kameneva and M.A. Wild, Capacity for red blood cell aggregation is higher in athletic mammalian species than in sedentary species, J. Appl. Physiol. 77 (1994), 1790-1794.
46. A.R. Pries, D. Neuhaus and P. Gaehtgens, Blood viscosity in tube flow, Am. J. Physiol. 263 (1992), H1770-H1778.
47. M.W. Rampling, Hemorheological disturbances in hypertension: influence of diabetes and smoking, Clin. Hemorheol. Microcirc. 16 (1996), 677-683.
48. M.W. Rampling, H.J. Meiselman, B. Neu and O.K. Baskurt, Influence of cell-specific factors on red blood cell aggregation, Biorheology 41 (2004), 91-112.
49. R.S. Rosenson and J.M. Hafner, Rheological changes in hypertensive patient treated with Ramipril, Clin. Hemorheol. Microcirc. 17 (1997), 41-46.
50. B. Sandhagen, G. Frithz, U. Waern and G. Ronquist, Increased whole blood viscosity combined with decreased erythrocyte fluidity in untreated patients with essential hypertension, J. Int. Med. 228 (1990), 625-626.
51. H. Schmid-Schonbein, Hemorheology, in: Comprehensive Human Physiology, R. Greger and U. Windkorst, eds, Springer-Verlag, Berlin, 1991, pp. 1747-1782.
52. C.N. Sessler and W. Shepherd, New concepts in sepsis, Cur. Opin. Crit. Care 8 (2002), 465-472.
53. C.G.C. Spencer, D. Gurney, D.C. Felmeden, A.D. Blann, D.G. Beevers and G.Y. Lip, Platelet and hemorheological markers in high-risk hypertensives are improved by tighter blood pressure control and cardiovascular risk management, J. Int. Med. 255 (2004), 59-67.
54. J.F. Stoltz, Hemorheologie et Aggregation Erythrocytaire, Editions Medicales Internationales, Cachan, France, 1994.
55. J.F. Stoltz, M. Singh and P. Riha, Hemorheology in Practice, IOS Press, Amsterdam, 1999.
56. J.F. Stoltz, F. Zannad, Y. Kdher, B. DesBoses, R.E. Ghawi, B. Meilhac, G. Cauchois, M. Gentils and S. Muller, Influence of a calcium antagonist on blood rheology and arterial compliance in hypertension: comparison with a thiazide diuretic, Clin. Hemorheol. Microcirc. 21 (1999), 201-208.
57. A.G. Tsai, C. Acero, P.R. Nance, P. Cabrales, J.A. Frangos, D.G. Buerk and M. Intaglietta, Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion, Am. J. Physiol. Heart Circ. Physiol. 288 (2005), H1730-H1739.
58. A.G. Tsai, B. Friesenecker, M. McMarthy, H. Sakai and M. Intaglietta, Plasma viscosity regulates capillary perfusion during extreme hemodilution in a hamster skin fold model, Am. J. Physiol. Heart Circ. Physiol. 275 (1998), H2170-H2180.
59. C.M. Verkeste, P.F. Boekkooi, P.R. Saxena and L.L. Peeters, Increased red cell aggregation does not reduce uteroplacental blood flow in the awake, hemoconcentrated, late-pregnant guinea pig, Pediatr. Res. 31 (1992), 91-93.
60. E. Vicaut, Opposite effects of red blood cell aggregation on resistance to blood flow, J. Cardiovasc. Surg. 36 (1995), 361-368.
61. O. Yalcin, M. Uyuklu, J.K. Armstrong, H.J. Meiselman and O.K. Baskurt, Graded alterations of red blood cell aggregation influence in vivo blood flow resistance, Am. J. Physiol. 287 (2004), H2644-H2650.